A new report from the Alliance for Childhood Cancer and the American Cancer Society emphasizes the gaps and obstacles that face pediatric cancer research, showing that it is important to guarantee long-term health for pediatric cancer survivors.
Recent research demonstrates that Alzheimer’s diagnoses can be made many years after a person’s brain begins to develop dementia, prompting scientists to develop diagnostic tests that detect Alzheimer’s before it becomes dementia.
The Alzheimer’s Disease Neuroimaging initiative (ADNI), part of the National Institutes of Health study of brain and fluid biomarkers of Alzheimer’s, recently received new funding to make progress with launching ADNI3.
The American Heart Association Rapid Access Journal Report recently stated that the risk of suddenly dying from cardiac problems is significantly higher among patients who have increased thyroid hormone levels.
The American Heart Association (AHA) and the Patient-Centered Outcomes Research Institute (PCORI) recently said they have developed a new Researcher and Clinician Challenge to improve care for cardiovascular diseases.
Officials with the U.S. Food and Drug Administration recently granted marketing approval for two Trevo clot retrieval devices to treat strokes because of blood clots (ischemic) and to decrease speech difficulties, paralysis and similar stroke disabilities.
Leaders with the U.S. Food and Drug Administration (FDA) recently released a revised guidance recommendation, encouraging universal testing for Zika virus in all whole blood as well as blood components within the U.S. and its territories.
GlaxoSmithKline (GSK) plans to present updates about emerging studies from the company’s comprehensive respiratory portfolio of investigational programs, approved medicines and scientific collaborations.